WO2001073356A1 - Biostatic filter - Google Patents

Biostatic filter Download PDF

Info

Publication number
WO2001073356A1
WO2001073356A1 PCT/AU2001/000339 AU0100339W WO0173356A1 WO 2001073356 A1 WO2001073356 A1 WO 2001073356A1 AU 0100339 W AU0100339 W AU 0100339W WO 0173356 A1 WO0173356 A1 WO 0173356A1
Authority
WO
WIPO (PCT)
Prior art keywords
filter
composition according
air
agent
filtrate
Prior art date
Application number
PCT/AU2001/000339
Other languages
French (fr)
Inventor
Steven Kritzler
Original Assignee
Novapharm Research (Australia) Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NZ521751A priority Critical patent/NZ521751A/en
Application filed by Novapharm Research (Australia) Pty Ltd filed Critical Novapharm Research (Australia) Pty Ltd
Priority to MXPA02009500A priority patent/MXPA02009500A/en
Priority to DE60120943T priority patent/DE60120943T2/en
Priority to CA2404816A priority patent/CA2404816C/en
Priority to IL15197501A priority patent/IL151975A/en
Priority to EP01914836A priority patent/EP1269088B1/en
Priority to AU2001242108A priority patent/AU2001242108B9/en
Priority to AU4210801A priority patent/AU4210801A/en
Priority to US10/239,714 priority patent/US6802891B2/en
Priority to KR1020027012964A priority patent/KR100903715B1/en
Priority to JP2001571036A priority patent/JP4846164B2/en
Publication of WO2001073356A1 publication Critical patent/WO2001073356A1/en
Priority to HK03104215A priority patent/HK1052214A1/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D39/00Filtering material for liquid or gaseous fluids
    • B01D39/02Loose filtering material, e.g. loose fibres
    • B01D39/04Organic material, e.g. cellulose, cotton
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D46/00Filters or filtering processes specially modified for separating dispersed particles from gases or vapours
    • B01D46/0027Filters or filtering processes specially modified for separating dispersed particles from gases or vapours with additional separating or treating functions
    • B01D46/0028Filters or filtering processes specially modified for separating dispersed particles from gases or vapours with additional separating or treating functions provided with antibacterial or antifungal means
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2279/00Filters adapted for separating dispersed particles from gases or vapours specially modified for specific uses
    • B01D2279/50Filters adapted for separating dispersed particles from gases or vapours specially modified for specific uses for air conditioning

Definitions

  • This invention relates to air-conditioning systems and more particularly to a method of, and composition for, reduction in pathogens associated with the filters in such systems.
  • the invention has been developed primarily for use in air-conditioning
  • Air conditioning systems such as are commonly provided in office, residential, health care and other buildings incorporate air filters.
  • An example of such a filter employs non-woven polyester fibres as media to filter airborne particulates in excess of about 10 microns in size from the air, but filters are made from a wide variety of materials, in many different constructions and grades.
  • the function of the filter is to trap dust and particulate contaminants. This trapped matter (the "filtrate”) provides a haven for the growth of pathogens such as fungi, bacteria, viruses, allergens, yeasts, and moulds.
  • Conditions for the growth of such organisms are especially favourable during periods of high humidity such as may occur when the system is off, for example at night, but also arise during normal operation.
  • the presence of organisms is highly undesirable because they can cause illness or death in humans and animals, create odours and can damage or destroy a wide variety of materials.
  • endo toxins and mycotoxins which are breakdown components of fungal and bacterial cell walls and which are known human respiratory allergens. In some individuals they can trigger asthma attacks, and in all cases have been shown to cause immune response. Over a period of exposure this reduces the ability of the immune system to respond to antagonists and leaves the subject more prone to infection by bacteria, viruses, etc. Also of concern are fungal spores, bacterial spores and bacteria.
  • air filters are prepared from or include natural materials such as cellulose and in that case are rapidly degraded under moist conditions by certain fungi.
  • the invention provides an air filter including a composition, said composition including a biostatic or biocidal agent wherein the agent is adapted to migrate through particulates accumulating in use on the filter.
  • the biostatic or biocidal agent is selected to have bacteriostatic and/or fungistatic properties.
  • the particulates usually accumulate in layers and the biostatic or biocidal agent of the invention migrates through the layer to the outside surface (air/particulate interface) where organic matter would otherwise multiply.
  • the biocide is not bound to the filter surface but is adapted to migrate through the accumulating dust and particulate matter on the filter. Particles in the layer become coated with biocide or biostat.
  • the treatment is bacteriostatic or fungistatic. That is to say, it is sufficient that the treating agent stops colonisation on the filter rather than kills organisms in a colonised filter.
  • biocidal compositions may be used.
  • the invention provides a composition for application to an air filter including:
  • biocidal or biostatic agent is adapted to migrate through a filtrate accumulating, in use, on a surface of the air filter
  • composition further includes a surfactant and desirably a fluorosurfactant.
  • the composition includes one or more rheological additives for example a thickening agent, a gelling agent, or a viscosity modifier.
  • the invention provides a method of treating a filtrate on a filter including the step of adding to the filter or to the filtrate a biocidal or biostatic agent adapted to migrate through the filtrate
  • the invention provides a method of reducing airborne contaminants in air including the step of: treating a filter with an agent according to the second aspect, passing air through the filter whereby to accumulate contaminants as a filtrate on the filter , and allowing the biocide to migrate into the filtrate.
  • Fig 1 is a photomicrograph (x 100) of a new untreated air conditioning dust filter prior to use
  • Fig 2 is a photomicrograph ( lOO) showing an untreated filter similar to that of Fig 1 after 11 months in use in a building air conditioning system
  • Fig 3 is a photomicrograph (xlOO) showing a treated filter similar to that of Fig 1 after 11 months in use in a building air conditioning system
  • Fig 4 is a graph comparing the number of colony fonning units ("cfu's") per gram of a filter treated in accordance with the invention with an untreated filter as a function of time in use over 11 months BEST MODES OF PERFORMING THE INVENTION
  • the present inventor has discovered that the application of biocides to filter fibres as in the past is relatively ineffective because; while tins treatment can prevent fungal and biocidal activity directly on the filter fibres themselves, as dust accumulate on the filter, the outer surface of the dust becomes removed from the biocide bound to the filter fibres and pathogens then grow on the outside of this dusty residue (that is to say separated from the biocide treated fibres). Thus, as the filter clogs, the biocidal activity reduces. This explains why good results can be obtained in tests applying an innoculum to the prior art filters in the laboratory but without good results being obtained in actual installed continuous use.
  • the present invention provides a biocide which remains effective over much longer periods, if not over the useful life of the filter by providing a biocidal preparation adapted to migrate through the layer or layers of accumulating filtrate on the filter towards the surface (air/p articulate interface) where the micro-organisms tend to colonise, Surprisingly this can be achieved despite the higher velocity of air at the surface of such residue.
  • compositions according to the invention are effective because the humectant draws in water which acts as a vehicle for the solution and transport of biostat or biocide (or of a combination of biostats and/or of biocides).
  • the surface tension of the vehicle is effectively lowered by the one or more surface active agents.
  • the biocidal composition is permitted to migrate to the outermost surface by the aqueous vehicle, maintaining its efficacy against pathogenic organisms, which otherwise would grow on the surface of the particulate layer and in gaps in the particulate residue.
  • the biocide wets the exterior surface of individual particles as well as the exterior surface of the particulate layer.
  • Example 1 In a preferred embodiment of the invention, an air filter is coated with a solution containing the dispersion or solution of biocide and humectant in a solvent.
  • an air conditioning filter according to Australian grade "F5" was treated .
  • the filter was made from a needled non- oven polyester fibre fabric and had a total surface area of about 3.5 square metres.
  • the filter thickness was 10-12 mm and its density was about 280-300 grams per square metre (gsm). A typical fibre diameter would be in the range of 6-15 denier.
  • the filter was treated by spraying with a solution having a formulation as shown in example 2.
  • Example 2 A basic formulation of a treating solution is as follows: Calcium chloride (humectant) 5-25% Kathon 886MW (biostat) 0.04%
  • Kathon 886MW is a preservative obtainable from Rohm & Haas Corp.
  • Fluorad FC 129 is a fluorosurfactant available from 3M corp. Example 3
  • a preferred formulation for the treating solution is as follows: Calcium chloride (humectant) 14 -18%
  • rheological additives e.g. viscosity modifiers, gelling agents, thixotropic agents or the like
  • the type and quantity of rheological additive can be selected having regards to conditions of use.
  • the preferred treatment is very strongly hydroscopic, taking in moisture from the air passing through the filter and becoming a liquid. This liquids penetration into an accumulating filtrate layer is further enhanced by the incorporation in the treatment of a surface active agent which ensures penetration against the air flow by virtue of low surface tension.
  • the biocides in the formulation are water soluble or partly water soluble and therefore migrate into and through the filtrate layer as part of the treatment.
  • Other active ingredients may be incorporated into the formulation for permeation through the filtrate, for example fire retardants, airflow promoters or viscosity reducing agents, deodorisers and so forth.
  • Example 4 A filter according to example 1 was treated by spraying with a solution according to example 3 to a level of 230 ml of treating solution per square meter. The treated filter was then dried using dry air. It will be understood that the filter could be coated by dipping or any other convenient method and dried using heat, a vacuum or by any other suitable means or combination of means. The dried filter was then placed into a sealed container, such as a sealed plastic bag, until ready for use.
  • the filter When the filter was to be used, it was removed from its sealed container, and placed in its operational position in an air-conditioning system.
  • the humectant in a filter prepared in accordance with the invention will begin to absorb water from the environment. This absorption continues through to a stage where a saturated solution of the biocide forms in which the concentration depends on the relative humidity of the air. During the liquefaction process, the biocidal components are partially or completely dissolved in the humectant solution along with the surfactants.
  • the resulting liquid treatment solution has an extremely low surface tension and high osmolality making it an ideal penetrant.
  • This treatment progressively penetrates and encapsulates the contaminant particles.
  • the encapsulating penetrating treatment which contains an efficacious level of biocide not only kills micro-organisms carried on the airbome contaminant, but also ensures that no microbiological activity takes place in the layer of filtrate itself.
  • the growth of bacteria and pathogens is naturally higher than in diy air.
  • the present invention provides greater biocidal activity when it is most needed, i.e. during times of high humidity. Reduced biocidal activity may be a consequence of drier air, however it is anticipated that the number and growth of pathogens during such dry conditions would not be so high. These conditions result in an extension of the biocidal life-time of the filter.
  • the present invention is not directed towards the prevention of clogging of the filter by preventing growth of the biomass, but rather is directed to controlling colonisation by organisms on the filter and in the accumulating residue and ultimately to produce air which is reduced in pathogens.
  • Example 5
  • Filters treated according to example 4 were placed in service.
  • the treated filters were found to be effective in service for periods of six months or more. At the end of six months, the filter was removed, cleaned, and retreated with fresh composition according to example 1.
  • Spore forming materials put a load on the human immune system of those breathing the air. Dead cells, if they become airborne, cause asthma in those susceptible.
  • a further advantage of the present invention is that the humectant maintains a level of moisture at the filtrate surface which reduces spore and cell refluidization.
  • Figures 1-3 are photomicrographs at x 100 magnification showing the effect of treatment after 11 months in use (fig 3) compared to untreated filter material before use (fig 1) and after 11 months use (fig 2).
  • a comparison of the used untreated sample of fig 2 with the unused sample of fig 1 shows that use results in significant growth of fungal filaments (which appear as fine threads) about the larger diameter filter fibres. Entrapped dirt and dust particles are also visible after use.
  • the treated filter of fig 3 shows no significant growth of micro-organisms after 11 months exposure although entrapped dirt and dust particles are' naturally clearly visible.
  • Example.6 A series of identical new filters were taken and 20% of them were treated as in . example 4 with the composition of example 3. The remaining 80% of the series were left untreated. The treated and untreated filters were put into the same air handling system, such that the treated filters were alternated with untreated filters. On a monthly basis samples were taken from both a treated and an adjacent untreated filter and the number of viable fungal and bacterial species were counted. The results (expressed as colony forming units ("cfu's”)/gram of filter are shown in fig 4 as a function of time in months. The rate of colonisation of the treated filter was not significantly different from that of the untreated filter during the first month.
  • cfu's colony forming units
  • Suitable biocides for use in the invention include, but are not limited to, 2-bromo- 2-nitropropane-l,3-diol (Bronopol); Isothiazolines such as methyl, or chloromethyl isothiazolinone (Kathon 886 MW); Methyl or propyl or butyl parahydroxybenzoates; sorbic acid, benzoic acid and salts of these acids, phenoxy ethanol; triclosan; diclosan; dichlorophen; chlorhexidine gluconate, orthophenylphenol; benzalkonium halides; and other quaternary biocides orthobenzylparachlorophenol, substituted diphenyl ethers.
  • Bronopol 2-bromo- 2-nitropropane-l,3-diol
  • Isothiazolines such as methyl, or chloromethyl isothiazolinone (Kathon 886 MW)
  • a preferred humectant for use in the invention is calcium chloride.
  • examples of other humectants are glycerol, sorbitol, ethylene glycol, PEG, propylene glycol, 1,3 butylene glycol, PCA (2-Pyrrolidone-5-carboxylic acid), sodium sulphate, sodium hydroxide, lactic acid and derivatives, sodium chloride and the like.
  • humectants also act as surfactants.
  • One example is sodium dioctylsulphosuccinate.
  • a preferred surfactant class for use in the invention is fluoro surfactants, such as Fluorad FC129. These are preferred because they have a profound ability to reduce surface tension. However other surfactants can be employed.
  • the surfactant may be non-ionic (e.g.
  • anionic surfactants such as sodium dodecylbenzenesulphonate, sodium dioctylsulphosuccinate, sodium salts of sulphonated or sulphated organic ethoxylates or propoxylates
  • catio ic surfactants such as Cetrimonium Chloride or such as secondary, tertiary and quaternary organoamines
  • amphoteric surfactants such Cocamidopropylene Betaine
  • rheological agents which may be included are sodium carboxymethylcellulose; hydroxyethylcellulose; hydroxypropylcellulose; polyethylene glycols; polypropylene glycols; polyvinyl alcohol; polyvinyl acetate, polyvinylpyrrolidone and copolymers of these, hydroxypropyl guar, xanthan gum, chitosan, acrylated copolymers, polyacrylic polymers (carbopols) and the like.
  • water soluble polymers would be similarly advantageous.
  • composition in the examples was applied to the filter from an aqueous solution or suspension, it may be possible and advantageous to apply the humectant and biostat to the filter as a solid or from a non aqueous solvent and such compositions are within the scope of the invention.
  • compositions according to the invention can be applied to filters of any material. Tests have been conducted with filters of polypropylene, viscose, rayon, cellulosics, and glass fibre. However the principle of operation herein described is adaptable to filters of other materials and of other construction (such as for example woven, non-woven, spunbond, meltblown, laminates and the like).
  • the treating agent may employ one or more biocides and may be formulated based on the principles herein taught in a variety of formulations.
  • a filter may be treated in situ by admitting a composition according to the invention as a spray downstream of the filter or by direct application (continuously or intermittently) of a biostat onto the filtrate layer of a filter in service, or prior to removal.
  • the treatment may also be reapplied to a filter removed from service, with or without removal of filtrate.

Abstract

The invention relates to an air filter including a composition which has a biostatic or biocidal agent adapted to migrate through particulates accumulating in use on the filter. The biocidal agent may have bacteriostatic and/or fungistatic properties and may optionally include a humectant, a surfactant or rheological additive. The invention also relates to compositions for treating filters and a method of reducing airborne contaminants in air.

Description

"BIOSTNTIC FILTER"
TECHNICAL FIELD
This invention relates to air-conditioning systems and more particularly to a method of, and composition for, reduction in pathogens associated with the filters in such systems. The invention has been developed primarily for use in air-conditioning
(including air cooling and air heating) systems, and will be described hereinafter with reference to this field of use. However, it will be appreciated that it is not limited to that particular use BACKGROUND ART Air conditioning systems such as are commonly provided in office, residential, health care and other buildings incorporate air filters. An example of such a filter employs non-woven polyester fibres as media to filter airborne particulates in excess of about 10 microns in size from the air, but filters are made from a wide variety of materials, in many different constructions and grades. The function of the filter is to trap dust and particulate contaminants. This trapped matter (the "filtrate") provides a haven for the growth of pathogens such as fungi, bacteria, viruses, allergens, yeasts, and moulds. Conditions for the growth of such organisms are especially favourable during periods of high humidity such as may occur when the system is off, for example at night, but also arise during normal operation. The presence of organisms is highly undesirable because they can cause illness or death in humans and animals, create odours and can damage or destroy a wide variety of materials.
Of particular concern in terms of human health and safety are endo toxins and mycotoxins which are breakdown components of fungal and bacterial cell walls and which are known human respiratory allergens. In some individuals they can trigger asthma attacks, and in all cases have been shown to cause immune response. Over a period of exposure this reduces the ability of the immune system to respond to antagonists and leaves the subject more prone to infection by bacteria, viruses, etc. Also of concern are fungal spores, bacterial spores and bacteria.
The prevention of spore germination and microbial survival in air filtration devices would help reduce the risk of illness and hypersensitivity reactions. It would also increase the useful life of the filtration devices. Microbial activity shortens the life of the filter itself because the increase in biomass on and in the filter can clog pores, lessen air- flow and increase back pressure in the system. In some cases, air filters are prepared from or include natural materials such as cellulose and in that case are rapidly degraded under moist conditions by certain fungi.
It is a major concern in health care facilities such as hospitals and nursing homes that dangerous infectious diseases may be spread by a wide variety of micro-organisms. The problem is exacerbated in such facilities because many of the patients are in a weakened condition due to their primary health care problem. Micro-organisms that would not be a major tlireat to a healthy person can be fatal to a patient with a diminished capacity to defend themselves from infection.
Increasing attention is also being paid to other environments such as public buildings, since if pathogenic microorganisms find their way via conditioned air or ventilation shafts, into a building they can be rapidly circulated throughout the building thereby greatly increasing the likelihood of the spread of infection and disease.
One proposed solution to this problem has been to coat filter materials with a biocidal composition. The biocides have been bound onto or into the filter fibres for example by inclusion within polymers prior to extrusion as filter fibres. The present inventor has discovered that such so-called "antimicrobial" filters are biostatically effective when the surface of an unused "antimicrobial" filter material is inoculated with bacteria and/or fungal contaminant in the laboratory, but that the filter becomes progressively ineffective with passage of time in actual use in an air-conditioning system. Consequently the filter should be frequently removed for cleaning and retreatment or replaced. Removal is costly and inconvenient in terms of labour required and downtime, as well as being potentially hazardous, while retreatment or replacement is expensive. Typically the filters are only removed when the airflow resistance becomes unacceptable.
Any discussion of the prior art throughout the specification should in no way be considered as an admission that such prior art is widely known or forms part of the common general knowledge in the field.
It is an object of the present invention to overcome or ameliorate at least one of the deficiencies of the prior art, or to provide a useful alternative.
Many regions of the world employ heated filtered air in buildings as a means of central heating. It will be understood that the furnace and other filters of such systems contribute to the same hazards as described above for air conditioning filters and the invention is not limited to any particular kind of filter or airflow system. It will also be understood that the invention is equally applicable to filters of different kinds and grades, for example to hepafilters. BRIEF DESCRIPTION OF THE INVENTION
. According to a first aspect, the invention provides an air filter including a composition, said composition including a biostatic or biocidal agent wherein the agent is adapted to migrate through particulates accumulating in use on the filter. For preference, the biostatic or biocidal agent is selected to have bacteriostatic and/or fungistatic properties. The particulates usually accumulate in layers and the biostatic or biocidal agent of the invention migrates through the layer to the outside surface (air/particulate interface) where organic matter would otherwise multiply.
In filters according to the invention the biocide is not bound to the filter surface but is adapted to migrate through the accumulating dust and particulate matter on the filter. Particles in the layer become coated with biocide or biostat.
It will be understood that it is sufficient that the treatment is bacteriostatic or fungistatic. That is to say, it is sufficient that the treating agent stops colonisation on the filter rather than kills organisms in a colonised filter. However biocidal compositions may be used.
According to a second aspect, the invention provides a composition for application to an air filter including:
- a water soluble biocidal or biostatic agent,
- -and a humectant whereby the biocidal or biostatic agent is adapted to migrate through a filtrate accumulating, in use, on a surface of the air filter;
It is highly preferred that the composition further includes a surfactant and desirably a fluorosurfactant.
- In highly preferred embodiments the composition includes one or more rheological additives for example a thickening agent, a gelling agent, or a viscosity modifier. According to a third aspect, the invention provides a method of treating a filtrate on a filter including the step of adding to the filter or to the filtrate a biocidal or biostatic agent adapted to migrate through the filtrate
According to a fourth aspect, the invention provides a method of reducing airborne contaminants in air including the step of: treating a filter with an agent according to the second aspect, passing air through the filter whereby to accumulate contaminants as a filtrate on the filter , and allowing the biocide to migrate into the filtrate. BRIEF DESCRIPTION OF THE DRA WINGS
Fig 1 is a photomicrograph (x 100) of a new untreated air conditioning dust filter prior to use;
Fig 2 is a photomicrograph ( lOO) showing an untreated filter similar to that of Fig 1 after 11 months in use in a building air conditioning system; Fig 3 is a photomicrograph (xlOO) showing a treated filter similar to that of Fig 1 after 11 months in use in a building air conditioning system; and
Fig 4 is a graph comparing the number of colony fonning units ("cfu's") per gram of a filter treated in accordance with the invention with an untreated filter as a function of time in use over 11 months BEST MODES OF PERFORMING THE INVENTION
Various embodiments of the invention will now be more particularly described by way of example only and with reference to the figures.
The present inventor has discovered that the application of biocides to filter fibres as in the past is relatively ineffective because; while tins treatment can prevent fungal and biocidal activity directly on the filter fibres themselves, as dust accumulate on the filter, the outer surface of the dust becomes removed from the biocide bound to the filter fibres and pathogens then grow on the outside of this dusty residue (that is to say separated from the biocide treated fibres). Thus, as the filter clogs, the biocidal activity reduces. This explains why good results can be obtained in tests applying an innoculum to the prior art filters in the laboratory but without good results being obtained in actual installed continuous use. In contrast, the present invention provides a biocide which remains effective over much longer periods, if not over the useful life of the filter by providing a biocidal preparation adapted to migrate through the layer or layers of accumulating filtrate on the filter towards the surface (air/p articulate interface) where the micro-organisms tend to colonise, Surprisingly this can be achieved despite the higher velocity of air at the surface of such residue.
Without wishing to be bound by theory, it is believed that compositions according to the invention are effective because the humectant draws in water which acts as a vehicle for the solution and transport of biostat or biocide (or of a combination of biostats and/or of biocides). In preferred embodiments of the invention the surface tension of the vehicle is effectively lowered by the one or more surface active agents. As the filtrate accumulates on the filter, and the humectant draws in water, the biocidal composition is permitted to migrate to the outermost surface by the aqueous vehicle, maintaining its efficacy against pathogenic organisms, which otherwise would grow on the surface of the particulate layer and in gaps in the particulate residue.
Preferably the biocide wets the exterior surface of individual particles as well as the exterior surface of the particulate layer.
Example 1 In a preferred embodiment of the invention, an air filter is coated with a solution containing the dispersion or solution of biocide and humectant in a solvent. In the present example an air conditioning filter according to Australian grade "F5" was treated . The filter was made from a needled non- oven polyester fibre fabric and had a total surface area of about 3.5 square metres. The filter thickness was 10-12 mm and its density was about 280-300 grams per square metre (gsm). A typical fibre diameter would be in the range of 6-15 denier. The filter was treated by spraying with a solution having a formulation as shown in example 2.
Example 2 A basic formulation of a treating solution is as follows: Calcium chloride (humectant) 5-25% Kathon 886MW (biostat) 0.04%
Fluorad FC129 (surfactant) 0.01%
Water qs 100%
Note: Kathon 886MW is a preservative obtainable from Rohm & Haas Corp. Fluorad FC 129 is a fluorosurfactant available from 3M corp. Example 3
A preferred formulation for the treating solution is as follows: Calcium chloride (humectant) 14 -18%
Kathon 886 MW (biostat) 0.04%
Fluorad FC 129 (surfactant) 0.01 % Vinyl ether/maleic anliydride copolymer* 0.8%
(viscosity modifier)
Water qs 100%
*Gantrez available from ISP Corp.
It is desirable to incorporate one or more rheological additives (e.g. viscosity modifiers, gelling agents, thixotropic agents or the like) into the treatment. These control the viscosity of the vehicle to prevent fine droplets of dissolved treating agent from being blown from the filter by the vigorous passage of air, and to assist in retaining the solution on the filter. The type and quantity of rheological additive can be selected having regards to conditions of use. The preferred treatment is very strongly hydroscopic, taking in moisture from the air passing through the filter and becoming a liquid. This liquids penetration into an accumulating filtrate layer is further enhanced by the incorporation in the treatment of a surface active agent which ensures penetration against the air flow by virtue of low surface tension. The biocides in the formulation are water soluble or partly water soluble and therefore migrate into and through the filtrate layer as part of the treatment.
. Other active ingredients may be incorporated into the formulation for permeation through the filtrate, for example fire retardants, airflow promoters or viscosity reducing agents, deodorisers and so forth.
Example 4 A filter according to example 1 was treated by spraying with a solution according to example 3 to a level of 230 ml of treating solution per square meter. The treated filter was then dried using dry air. It will be understood that the filter could be coated by dipping or any other convenient method and dried using heat, a vacuum or by any other suitable means or combination of means. The dried filter was then placed into a sealed container, such as a sealed plastic bag, until ready for use.
When the filter was to be used, it was removed from its sealed container, and placed in its operational position in an air-conditioning system. In use, the humectant in a filter prepared in accordance with the invention will begin to absorb water from the environment. This absorption continues through to a stage where a saturated solution of the biocide forms in which the concentration depends on the relative humidity of the air. During the liquefaction process, the biocidal components are partially or completely dissolved in the humectant solution along with the surfactants.
The resulting liquid treatment solution has an extremely low surface tension and high osmolality making it an ideal penetrant. As the filter progressively removes airborne contaminants which accmnulate as a filtrate layer, this treatment progressively penetrates and encapsulates the contaminant particles. The encapsulating penetrating treatment which contains an efficacious level of biocide not only kills micro-organisms carried on the airbome contaminant, but also ensures that no microbiological activity takes place in the layer of filtrate itself. In humid air, the growth of bacteria and pathogens is naturally higher than in diy air. Thus, the present invention provides greater biocidal activity when it is most needed, i.e. during times of high humidity. Reduced biocidal activity may be a consequence of drier air, however it is anticipated that the number and growth of pathogens during such dry conditions would not be so high. These conditions result in an extension of the biocidal life-time of the filter.
The present invention is not directed towards the prevention of clogging of the filter by preventing growth of the biomass, but rather is directed to controlling colonisation by organisms on the filter and in the accumulating residue and ultimately to produce air which is reduced in pathogens. Example 5
Filters treated according to example 4 were placed in service. The treated filters were found to be effective in service for periods of six months or more. At the end of six months, the filter was removed, cleaned, and retreated with fresh composition according to example 1. In conducting these experiments it was noted that spore forming materials if allowed to dry out on the filter tended easily to become airborne and redistributed in the air stream and also tend to be more resistant to biocide when diy. Spore forming materials put a load on the human immune system of those breathing the air. Dead cells, if they become airborne, cause asthma in those susceptible. A further advantage of the present invention is that the humectant maintains a level of moisture at the filtrate surface which reduces spore and cell refluidization.
Figures 1-3 are photomicrographs at x 100 magnification showing the effect of treatment after 11 months in use (fig 3) compared to untreated filter material before use (fig 1) and after 11 months use (fig 2). A comparison of the used untreated sample of fig 2 with the unused sample of fig 1 shows that use results in significant growth of fungal filaments (which appear as fine threads) about the larger diameter filter fibres. Entrapped dirt and dust particles are also visible after use. In contrast, the treated filter of fig 3 shows no significant growth of micro-organisms after 11 months exposure although entrapped dirt and dust particles are' naturally clearly visible.
Example.6 A series of identical new filters were taken and 20% of them were treated as in . example 4 with the composition of example 3. The remaining 80% of the series were left untreated. The treated and untreated filters were put into the same air handling system, such that the treated filters were alternated with untreated filters. On a monthly basis samples were taken from both a treated and an adjacent untreated filter and the number of viable fungal and bacterial species were counted. The results (expressed as colony forming units ("cfu's")/gram of filter are shown in fig 4 as a function of time in months. The rate of colonisation of the treated filter was not significantly different from that of the untreated filter during the first month. However thereafter the cfu's/gram climbed to in excess of Log 6 organisms per gram of clean filter material, whilst the corresponding figure for the treated filter substantially stabilised within two months at about Log 2 cfu's/ gram of clean filter material - a dramatically improved result.
Suitable biocides for use in the invention include, but are not limited to, 2-bromo- 2-nitropropane-l,3-diol (Bronopol); Isothiazolines such as methyl, or chloromethyl isothiazolinone (Kathon 886 MW); Methyl or propyl or butyl parahydroxybenzoates; sorbic acid, benzoic acid and salts of these acids, phenoxy ethanol; triclosan; diclosan; dichlorophen; chlorhexidine gluconate, orthophenylphenol; benzalkonium halides; and other quaternary biocides orthobenzylparachlorophenol, substituted diphenyl ethers. A preferred humectant for use in the invention is calcium chloride. Examples of other humectants are glycerol, sorbitol, ethylene glycol, PEG, propylene glycol, 1,3 butylene glycol, PCA (2-Pyrrolidone-5-carboxylic acid), sodium sulphate, sodium hydroxide, lactic acid and derivatives, sodium chloride and the like. Those skilled in the art will have no difficulty in selecting suitable humectants having regard to the construction materials in the system and the composition of the filter based on the disclosure herein contained. Some humectants also act as surfactants. One example is sodium dioctylsulphosuccinate.
A preferred surfactant class for use in the invention is fluoro surfactants, such as Fluorad FC129. These are preferred because they have a profound ability to reduce surface tension. However other surfactants can be employed. By way of example only, the surfactant may be non-ionic ( e.g. ethoxylates, propoxylates and block co-polymers of these two), anionic surfactants (such as sodium dodecylbenzenesulphonate, sodium dioctylsulphosuccinate, sodium salts of sulphonated or sulphated organic ethoxylates or propoxylates), catio ic surfactants (such as Cetrimonium Chloride or such as secondary, tertiary and quaternary organoamines) or even amphoteric surfactants (such Cocamidopropylene Betaine) . Examples of rheological agents which may be included are sodium carboxymethylcellulose; hydroxyethylcellulose; hydroxypropylcellulose; polyethylene glycols; polypropylene glycols; polyvinyl alcohol; polyvinyl acetate, polyvinylpyrrolidone and copolymers of these, hydroxypropyl guar, xanthan gum, chitosan, acrylated copolymers, polyacrylic polymers (carbopols) and the like. However many other water soluble polymers would be similarly advantageous.
Although the composition in the examples was applied to the filter from an aqueous solution or suspension, it may be possible and advantageous to apply the humectant and biostat to the filter as a solid or from a non aqueous solvent and such compositions are within the scope of the invention.
It will be understood that compositions according to the invention can be applied to filters of any material. Tests have been conducted with filters of polypropylene, viscose, rayon, cellulosics, and glass fibre. However the principle of operation herein described is adaptable to filters of other materials and of other construction ( such as for example woven, non-woven, spunbond, meltblown, laminates and the like).
It will be understood that the treating agent may employ one or more biocides and may be formulated based on the principles herein taught in a variety of formulations. Although it is preferred to pre-treat filters, a filter may be treated in situ by admitting a composition according to the invention as a spray downstream of the filter or by direct application (continuously or intermittently) of a biostat onto the filtrate layer of a filter in service, or prior to removal. The treatment may also be reapplied to a filter removed from service, with or without removal of filtrate.
Although the invention has been described with reference to specific examples, it will be appreciated by those skilled in the art that the invention may be embodied in other forms.

Claims

THE CLAIMS OF THEINVENTIONAREAS FOLLOWS
1. An air filter including a composition, said composition including a biostatic or biocidal agent wherein the agent is adapted to migrate through particulates accumulating in use on the filter.
2. An air filter according to claim 1 wherein the biostatic or biocidal agent is selected to have bacteriostatic and/or fungistatic properties.
3. An air filter according to claim 1 or 2 which after 3 months in normal use produces at least log 1 reduction in cfu's /gram of clean filter material in comparison with an untreated filter under the same conditions.
4. A composition for application to an air filter, said composition including:
- a water soluble biocidal or biostatic agent,
- and a humectant whereby the biocidal or biostatic agent is adapted to migrate through a filtrate accumulating, in use, on a surface of the air filter.
5. A composition according to claim 4 further including a surfactant.
6. A composition according to claim 4 further including a fluorosurfactant.
7. A composition according to any one of claims 4 to 6 further including one or more rheological additives.
8. A composition according to claim 7 wherein a rheological additive is a thickening agent, a gelling agent, or a viscosity modifier.
9. A composition according to any one of claims 4 to 8 wherein the biocidal or biostatic agent is selected from 2-bromo-2-nitropropane-l,3-diol, isothiazolines, methyl or propyl or butyl parahydroxybenzoates; sorbic acid, benzoic acid and salts of these acids, phenoxy ethanol; triclosan; diclosan; dichlorophen; chlorhexidine gluconate, orthophenylphenol; quaternary biocides, orthobenzylparachlorophenol, and substituted diphenyl ethers.
10. A composition according to any one of claims 4 to 9 wherein the agent is 2-bromo- 2-nitropropane- 1 ,3 -diol.
11. A composition according to any one of claims 4 to 10 wherein the humectant is selected from calcium chloride, glycerol, sorbitol, ethylene glycol, PEG, propylene glycol, 1,3 butylene glycol, PCA (2-Pyrrolidone-5-carboxylic acid), sodium sulphate, sodium hydroxide, lactic acid and derivatives thereof, sodium chloride and sodium dioctylsulphosuccinate.
12. A composition according to any one of claims 4 to 11 wherein the humectant is calcium chloride.
13. A composition according to claim 7 wherein a rheological additive is one or more compound selected from sodium carboxymethylcellulose; hydroxyethylcellulose; hydroxypropylcellulose; polyethylene glycols; polypropylene glycols; polyvinyl alcohol; polyvinyl acetate, polyvinylpyrrolidone and copolymers of these, hydroxypropyl guar, xanthan gum, chitosan, acrylated copolymers, polyacrylic polymers (carbopols) and water soluble polymers
14. A composition according to any one of claims 4 to 13 wherein a rheological additive is vinyl ether/maleic anhydride copolymer.
15. A composition according to any one of claims 4 to 14 substantially as herein described.
16. A filter when treated with a composition according to any one of claims 4 to 15
17. . A method of treating a filtrate on a filter including the step of adding to the filter or to the filtrate a biocidal or biostatic agent adapted to migrate through the filtrate.
18. A method of reducing airborne contaminants in air including the steps of: treating a filter with a composition according to any one of claims 4 to 15; passing air through the filter whereby to accumulate contaminants as a filtrate on the filter; and allowing the biocide to migrate into the filtrate.
19. N method of reducing airborne contaminants in air including the step of: treating a filter with an biocidal or biostatic agent; passing air through the filter whereby to accumulate contaminants as a filtrate on the filter; and allowing the biocide to migrate throughout the filtrate.
20. N method according to any one of claim 17s to 19 and substantially as herein described with reference to any one of the examples.
PCT/AU2001/000339 2000-03-29 2001-03-27 Biostatic filter WO2001073356A1 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
EP01914836A EP1269088B1 (en) 2000-03-29 2001-03-27 Biostatic filter
MXPA02009500A MXPA02009500A (en) 2000-03-29 2001-03-27 Biostatic filter.
DE60120943T DE60120943T2 (en) 2000-03-29 2001-03-27 BIOSTATIC FILTER
CA2404816A CA2404816C (en) 2000-03-29 2001-03-27 Biostatic filter
IL15197501A IL151975A (en) 2000-03-29 2001-03-27 Biostatic filter
NZ521751A NZ521751A (en) 2000-03-29 2001-03-27 Filter adapted for long lasting biocidal or biostatic activity by applying a water soluable biocidal or biostatic agent and a humectant
AU2001242108A AU2001242108B9 (en) 2000-03-29 2001-03-27 Biostatic filter
KR1020027012964A KR100903715B1 (en) 2000-03-29 2001-03-27 Biostatic filter
US10/239,714 US6802891B2 (en) 2000-03-29 2001-03-27 Biostatic filter
AU4210801A AU4210801A (en) 2000-03-29 2001-03-27 Biostatic filter
JP2001571036A JP4846164B2 (en) 2000-03-29 2001-03-27 Air filter
HK03104215A HK1052214A1 (en) 2000-03-29 2003-06-12 Biostatic filter

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ6563A AUPQ656300A0 (en) 2000-03-29 2000-03-29 Biostatic filter
AUPQ6563 2000-03-29

Publications (1)

Publication Number Publication Date
WO2001073356A1 true WO2001073356A1 (en) 2001-10-04

Family

ID=3820659

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU2001/000339 WO2001073356A1 (en) 2000-03-29 2001-03-27 Biostatic filter

Country Status (20)

Country Link
US (1) US6802891B2 (en)
EP (1) EP1269088B1 (en)
JP (2) JP4846164B2 (en)
KR (1) KR100903715B1 (en)
CN (1) CN1186569C (en)
AR (1) AR027729A1 (en)
AT (1) ATE331190T1 (en)
AU (1) AUPQ656300A0 (en)
CA (1) CA2404816C (en)
DE (1) DE60120943T2 (en)
DK (1) DK1269088T3 (en)
ES (1) ES2269362T3 (en)
IL (1) IL151975A (en)
MX (1) MXPA02009500A (en)
MY (1) MY124876A (en)
NZ (1) NZ521751A (en)
PT (1) PT1269088E (en)
TW (1) TW531443B (en)
WO (1) WO2001073356A1 (en)
ZA (1) ZA200207791B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004103071A1 (en) * 2003-05-21 2004-12-02 Novapharm Research (Australia) Pty Ltd Biofilm growth prevention
WO2006058370A1 (en) * 2004-11-30 2006-06-08 Alpha Technologies Corporation Ltd Improved sterilising filter arrangement, apparatus & method
AU2004241665B2 (en) * 2003-05-21 2009-10-08 Novapharm Research (Australia) Pty Ltd Biofilm growth prevention
GR1010135B (en) * 2021-02-03 2021-12-06 Ηλεκτρονικα Μετρητικα Συστηματα Α.Ε., Three-action air-purifying device

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ656200A0 (en) * 2000-03-29 2000-04-20 Novapharm Research (Australia) Pty Ltd Chemical upgrading of filters
AUPQ656300A0 (en) * 2000-03-29 2000-04-20 Novapharm Research (Australia) Pty Ltd Biostatic filter
US20030075047A1 (en) * 2001-10-22 2003-04-24 Normand Bolduc Bactericidal after-filter device
EP1456137B1 (en) * 2001-12-22 2010-07-07 ContiTech Vibration Control GmbH Clarification basin membrane
US20060021302A1 (en) * 2004-07-30 2006-02-02 Bernard Bobby L Anti-microbial air filter
US20070012186A1 (en) * 2005-03-11 2007-01-18 Wilson Todd S System and method of dehumidifying and filtering air
WO2006113967A1 (en) * 2005-04-27 2006-11-02 Novapharm Research (Australia) Pty Ltd Biostatic filter and water insoluble biocide formulation therefor
WO2007070650A2 (en) 2005-12-14 2007-06-21 3M Innovative Properties Company Antimicrobial adhesive films
WO2007070649A2 (en) 2005-12-14 2007-06-21 3M Innovative Properties Company Antimicrobial coating system
US20070253909A1 (en) * 2006-05-01 2007-11-01 Medi-Flex, Inc. Aqueous Antiseptic Solution and Compatible Cationic Dye for Staining Skin
US20070254854A1 (en) * 2006-05-01 2007-11-01 Medi-Flex, Inc. Aqueous Antiseptic Solution and Compatible Anionic Dye for Staining Skin
US20080108674A1 (en) * 2006-05-01 2008-05-08 Enturia, Inc. Cationic antiseptic and dye formulation
JP2009541046A (en) * 2006-07-05 2009-11-26 チバ ホールディング インコーポレーテッド Dihalogeno-hydroxydiphenyl ether as antibacterial agent in water treatment
WO2008013555A1 (en) * 2006-07-26 2008-01-31 Watervisions International, Inc. Broad spectrum antimicrobial purification materials and methods for purifying fluids
EP1882511A3 (en) * 2006-07-26 2011-02-16 MANN+HUMMEL GmbH Filter medium with bacterial effect
US20090191250A1 (en) * 2008-01-28 2009-07-30 Water Visions International, Inc. Antimicrobial Composite Material and Method for Fluid Treatment
DE102008062125A1 (en) 2008-12-16 2010-07-15 Trovotech Gmbh Suspension for treating filters or filter materials, methods of treating filters or filter materials, and filters or filter materials having a biocidal coating
CA2786867C (en) 2010-01-18 2022-01-04 3M Innovative Properties Company Air filter with sorbent particles
DE102010049425A1 (en) * 2010-10-23 2012-04-26 Gea Heat Exchangers Gmbh Nonwoven storage filter, useful for general room and process air technology, preferably for bag filters of air conditioners, comprises fibers of polyolefin and/or polyester
DE102011104628A1 (en) 2011-06-06 2012-12-06 Mann + Hummel Gmbh Antimicrobial filter medium and filter module
US9756860B2 (en) * 2011-12-01 2017-09-12 Rohm And Haas Company Antimicrobial composition of ortho phenylphenol and silver
CN105013252B (en) * 2014-04-16 2016-08-24 黄山城市绿洲空气过滤器科技有限公司 A kind of coating and the application in air filtration thereof
MX2016014188A (en) * 2014-04-30 2017-06-06 K&N Eng Inc Filter oil formulation.
US10639588B2 (en) 2015-08-28 2020-05-05 Serionix, Inc. Gas filters for acidic contaminants
CN108136367A (en) 2015-08-28 2018-06-08 塞里奥尼克斯股份有限公司 For the pneumatic filter of alkaline pollutant
US10299473B2 (en) 2017-04-28 2019-05-28 American Sterilizer Company Low pH phenolic disinfectant without para tertiary amylphenol
CN108889034A (en) * 2018-07-27 2018-11-27 杭州和山科技有限公司 A kind of water pump sterilized filtering layer and its manufacturing process
KR102080849B1 (en) * 2019-03-22 2020-02-24 지에스건설 주식회사 Method for improving performance of pressure retarded osmosis process

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2202042A (en) * 1986-11-06 1988-09-14 Sanyo Electric Co Inhibiting microorganisms in air conditioners
WO1996022825A1 (en) * 1995-01-27 1996-08-01 Purafil, Inc. Improved fiber filter and methods of use thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2638180A (en) * 1949-12-21 1953-05-12 Herkimer Herbert Air filter
GB846458A (en) * 1959-04-30 1960-08-31 Fram Corp Air conditioner filter having germicidal properties
US3532637A (en) * 1967-04-05 1970-10-06 Gen Am Transport Solid regenerable absorber for acid gases
US3947576A (en) * 1973-09-27 1976-03-30 Mortell Company Synergistic biostatic composition
BE875445A (en) 1978-05-10 1979-07-31 Hoelter H MOTOR VEHICLE INTERIOR VENTILATION AIR FILTER
US4534775A (en) * 1982-03-02 1985-08-13 General Time Corp. Air treatment filter element and air treatment filter
PH23983A (en) * 1986-12-23 1990-02-09 Biopolymers Ltd Biostatic and biocidal composition
US5240484A (en) * 1987-07-21 1993-08-31 Southwest Manufacturers & Distributors, Inc. Antimicrobial vacuum cleaner bag
JPH0411945A (en) * 1990-04-27 1992-01-16 Japan Vilene Co Ltd Microbe adsorbent for gas phase
SE469925B (en) 1992-02-21 1993-10-11 Gibeck Respiration Ab A filter device for connection to a person's respiratory system comprising a housing containing a moisture-heat-exchanging material and a bacteria-absorbing filter consisting of a pleated, air-permeable material
ATE140632T1 (en) 1992-04-15 1996-08-15 Schuller Int Inc AIR FILTER AND METHOD FOR REDUCING THE AMOUNT OF MICROORGANISMS IN CONTAMINATED AIR
US5288298A (en) * 1992-06-22 1994-02-22 Aston William T Antimicrobial air filter and method of making same
US5501238A (en) 1993-01-11 1996-03-26 Von Borstel; Reid W. Cigarette filter containing a humectant
JP3250940B2 (en) * 1995-01-30 2002-01-28 松下精工株式会社 Anti-virus filter and air purifier and air purifier humidifier
JPH09313927A (en) * 1995-11-20 1997-12-09 Esupo Kk Air cleaning agent and air cleaning method
JP3712790B2 (en) * 1996-06-13 2005-11-02 松下エコシステムズ株式会社 Antifungal antibacterial antiviral filter
CA2216764A1 (en) * 1996-10-11 1998-04-11 Samuel Eugene Sherba Phenylamides as marine antifouling agents
DE19651351A1 (en) * 1996-12-10 1998-06-18 Riedel De Haen Ag Microbicidal mixtures
JPH10174823A (en) * 1996-12-17 1998-06-30 Mitsui Chem Inc Air filter
GB9626950D0 (en) 1996-12-27 1997-02-12 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
US5872111A (en) 1997-05-19 1999-02-16 Lever Brothers Company, Division Of Conopco, Inc. Compositions comprising glycosylamide surfactants
JP3715748B2 (en) * 1997-07-09 2005-11-16 株式会社ダスキン Filtration sheet
JPH11226326A (en) * 1998-02-16 1999-08-24 Toshiba Corp Filter and air cleaner
US6224655B1 (en) * 1998-11-03 2001-05-01 Pierre Messier Biostatic air filter
DE19931371A1 (en) * 1999-07-08 2001-01-11 Mhb Filtration Gmbh & Co Kg Filter material for gas filtration with biocidal properties
US6383273B1 (en) * 1999-08-12 2002-05-07 Apyron Technologies, Incorporated Compositions containing a biocidal compound or an adsorbent and/or catalyst compound and methods of making and using therefor
AUPQ656300A0 (en) * 2000-03-29 2000-04-20 Novapharm Research (Australia) Pty Ltd Biostatic filter
US6543753B1 (en) * 2001-10-12 2003-04-08 Environmental Dynamics, Inc. Air diffuser membrane treated with biocide

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2202042A (en) * 1986-11-06 1988-09-14 Sanyo Electric Co Inhibiting microorganisms in air conditioners
WO1996022825A1 (en) * 1995-01-27 1996-08-01 Purafil, Inc. Improved fiber filter and methods of use thereof

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004103071A1 (en) * 2003-05-21 2004-12-02 Novapharm Research (Australia) Pty Ltd Biofilm growth prevention
AU2004241665B2 (en) * 2003-05-21 2009-10-08 Novapharm Research (Australia) Pty Ltd Biofilm growth prevention
US8524799B2 (en) 2003-05-21 2013-09-03 Novapharm Research (Australia) Pty Ltd Biofilm growth prevention
WO2006058370A1 (en) * 2004-11-30 2006-06-08 Alpha Technologies Corporation Ltd Improved sterilising filter arrangement, apparatus & method
GR1010135B (en) * 2021-02-03 2021-12-06 Ηλεκτρονικα Μετρητικα Συστηματα Α.Ε., Three-action air-purifying device

Also Published As

Publication number Publication date
ZA200207791B (en) 2003-05-09
DE60120943D1 (en) 2006-08-03
EP1269088A4 (en) 2003-05-28
KR100903715B1 (en) 2009-06-19
DK1269088T3 (en) 2006-10-30
EP1269088A1 (en) 2003-01-02
JP2011218355A (en) 2011-11-04
US6802891B2 (en) 2004-10-12
JP5613623B2 (en) 2014-10-29
US20030116022A1 (en) 2003-06-26
EP1269088B1 (en) 2006-06-21
TW531443B (en) 2003-05-11
JP2003529041A (en) 2003-09-30
CN1427937A (en) 2003-07-02
CA2404816C (en) 2011-07-12
NZ521751A (en) 2004-06-25
CN1186569C (en) 2005-01-26
IL151975A0 (en) 2003-04-10
KR20030007487A (en) 2003-01-23
DE60120943T2 (en) 2007-02-15
AR027729A1 (en) 2003-04-09
ES2269362T3 (en) 2007-04-01
MXPA02009500A (en) 2004-07-30
AUPQ656300A0 (en) 2000-04-20
JP4846164B2 (en) 2011-12-28
MY124876A (en) 2006-07-31
IL151975A (en) 2005-07-25
CA2404816A1 (en) 2001-10-04
ATE331190T1 (en) 2006-07-15
PT1269088E (en) 2006-11-30

Similar Documents

Publication Publication Date Title
US6802891B2 (en) Biostatic filter
US7942957B2 (en) Air filter having antimicrobial property
EP1771210A1 (en) Anti-microbial air filter
KR20140024403A (en) Antimicrobial filter medium and filter module
JP2000070646A (en) Air purifying filter member
WO2022255885A1 (en) Filters containing terpene-loaded nanofibres for enhanced bactericidal, fungicidal and virucidal activity, preparation methods and applications thereof
AU2001242108B9 (en) Biostatic filter
US7232475B2 (en) Chemical upgrading of filters
AU2001242108A1 (en) Biostatic filter
US20220305417A1 (en) Anti-microbial, anti-allergenic bio-functional air filter medium and air filter element
WO2006113967A1 (en) Biostatic filter and water insoluble biocide formulation therefor
EP4161680A1 (en) The use of photothermal agents in the air filters
DE202007010383U1 (en) Filter medium with bacterial action
AU2001242106B2 (en) Chemical upgrading of filters
AU2005100225A4 (en) Chemical upgrading of filters
AU2001242106A1 (en) Chemical upgrading of filters

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2404816

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002/07791

Country of ref document: ZA

Ref document number: PA/a/2002/009500

Country of ref document: MX

Ref document number: 200207791

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 1020027012964

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 151975

Country of ref document: IL

ENP Entry into the national phase

Ref document number: 2001 571036

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: IN/PCT/2002/00958/DE

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 521751

Country of ref document: NZ

Ref document number: 2001242108

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2001914836

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 01809046X

Country of ref document: CN

Ref document number: 10239714

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001914836

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020027012964

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 521751

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 521751

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 2001242108

Country of ref document: AU

WWG Wipo information: grant in national office

Ref document number: 2001914836

Country of ref document: EP